Amir Lahav
Founder & CEO
SkyMedAI
A Strategic Advisor, Global thought Leader, and Clinical Neuroscientist at the forefront of Digital Health, Artificial Intelligence, and Modern Medicine. Over 20 years of experience across Clinical, Commercial, and Enterprise-wide Digital Transformation functions in academia, healthcare, medtech, and pharma.
Amir's work is focused on providing C-level advisory and mentorship for companies seeking sustainable growth and commercial success, especially as it relates to the development of pioneering technologies and clinically-validated AI solutions that benefit clinicians and patients across a wide range of therapeutic areas. He sits on the advisory board of multiple startups and hold strategic consulting roles with leading pharmaceutical companies.
During his time at Pfizer, Amir led the development of wearable tech and remote monitoring solutions for clinical trials, primarily in rare diseases. Prior to pharma, Amir was a PI on numerous clinical trials as a Neurology Faculty and Professor of Pediatrics at Harvard Medical School.
Amir's work is focused on providing C-level advisory and mentorship for companies seeking sustainable growth and commercial success, especially as it relates to the development of pioneering technologies and clinically-validated AI solutions that benefit clinicians and patients across a wide range of therapeutic areas. He sits on the advisory board of multiple startups and hold strategic consulting roles with leading pharmaceutical companies.
During his time at Pfizer, Amir led the development of wearable tech and remote monitoring solutions for clinical trials, primarily in rare diseases. Prior to pharma, Amir was a PI on numerous clinical trials as a Neurology Faculty and Professor of Pediatrics at Harvard Medical School.
